CRI market research report

Healthcare Cold Chain Monitoring Market—Forecast till 2027

$4950 – $7250

Healthcare Cold Chain Monitoring Market: Information by Component (Hardware (Sensors, Data Loggers, Real-Time Monitoring Devices, RFID Devices, Resistance Temperature Detectors, and Others), Software (Cloud Based and On-Premises),Temperature Type (Frozen and Chilled), Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others),End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027

SKU: MRFR220253 Category: Tag:

Description

Healthcare Cold Chain Monitoring Market—Forecast till 2027

  • Component (Hardware (Sensors, Data Loggers, Real-Time Monitoring Devices, RFID Devices, Resistance Temperature Detectors, and Others),
  • Software (Cloud Based and On-Premises),
  • Temperature Type (Frozen and Chilled), Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others),
  • End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others),
  • and Region (North America, Europe, Asia-Pacific, and Rest of the World

 

Market Overview

As per the statistics, the Healthcare cold chain monitoring market is anticipated to exhibit a significant CAGR of over 12.2% to surpass USD 5,345.6 million during the review period. The market expansion is relied upon to be biologics, like those utilized in quality treatment.

Further developing the current inventory chains to guarantee an emphasis on exact temperature monitoring, cold chain monitoring, and information logging can assist you with saving the trustworthiness of your item, setting aside cash, and giving better medicines to patients.

The healthcare cold chain monitoring market is expected to register healthy market growth owing to the rising requirement for cold chain monitoring in the healthcare industry and the growing use of IoT in the healthcare sector. Cold chain strategies in the medical care area help screen and shield bundles from harm because of temperature changes.

Cold chain monitoring is fundamental for medical services as it guarantees that the capacity of medications and different medications is kept up with at an ideal temperature till they arrive at their objections.

Numerous life sciences merchandise, like prescriptions, some clinical hardware, organs, and examples, require temperature-controlled capacity and dissemination to keep up with sub-atomic security, safeguarding, and augmentation of valuable life.

Segment Overview

The global healthcare cold chain monitoring market has been classified into components, temperature type, product, end-user, and region.
Based on the component segment, the market is divided into hardware and software. The hardware segment is subclassified into sensors, data loggers, real-time monitoring devices, RFID devices, resistance temperature detectors, and others. The software segment is subdivided into cloud-based and on-premises.

In terms of temperature type, the global market is bifurcated into chilled and frozen. The product segment categorizes the healthcare cold chain monitoring market into vaccines, biopharmaceuticals, clinical trial materials, and others. Based on end-user, the market has been categorized into biopharmaceutical companies, hospitals & clinics, research institutes, and others.

Regional Analysis

Geographically, the healthcare cold chain monitoring market is classified into Asia-Pacific, North America, Europe, and the Rest of the World.
North America is likely to drive the global market owing to the largest market share of 34.84% in 2020. The regional market growth is driven by the rising demand for customized storage and transportation to ensure the effectiveness of healthcare products, and the rising focus of organizations on improving business agility.

Europe is anticipated to register as the largest market owing to the adoption of cold chain monitoring solutions by the midsize healthcare industry. The Asia- Pacific market for healthcare cold chain monitoring is driven by the growing demand for these cloud solutions in biopharmaceutical companies.

Major Players

The major players in the healthcare cold chain monitoring market include Carrier (US), Monnit Corporation (US), Temptime Corporation (US), Cold Chain Technologies (US), Dickson (US), Spotsee (US), Berlinger & Co. AG (Switzerland), Testo SE & Co. KGaA (Germany), Emerson (US), Signatrol (UK), Haier Biomedical (Shandong), Rotronic (Switzerland), Elpro (Switzerland), Controlant (Iceland), Roambee Corporation (California), OnAsset Intelligence, Inc. (US), and Tive (US).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Related Report: Healthcare Supply Chain Management Market: Market Segments: By Product (Software Hardware and Services); By Mode of Delivery (On-premise, Cloud-based and Web-based); By End User (Healthcare Manufacturers, Healthcare Providers, Distributors and Logistics); and Region – 1Global Analysis of Market Size, Share & Trends for 2014 – 12020 and Forecasts to 2030

Bone And Joint Health Ingredient

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 1.1 MARKET SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 3 RESEARCH METHODOLOGY 4 MARKET DYNAMICS 4.1 INTRODUCTION 4.2 DRIVERS 4.2.1 GROWING NEED FOR COLD CHAIN MONITORING IN THE HEALTHCARE SECTOR 4.2.2 INCREASED USE OF IOT TECHNOLOGY IN THE HEALTHCARE SECTOR 4.2.3 DRIVERS IMPACT ANALYSIS 4.3 OPPORTUNITIES 4.3.1 RISING DEMAND FOR WAREHOUSE AUTOMATION IN COLD CHAIN STORAGE 4.3.2 GROWING INVESTMENTS IN PHARMACEUTICAL COLD CHAIN 4.4 CHALLENGES 4.4.1 MAINTAINING TEMPERATURE INTEGRITY THROUGHOUT THE SUPPLY CHAIN 5 MARKET FACTOR ANALYSIS 5.1 SUPPLY CHAIN ANALYSIS 5.1.1 COMPONENT MANUFACTURERS 5.1.2 SOFTWARE DEVELOPERS 5.1.3 SYSTEM INTEGRATORS 5.1.4 SOLUTION/SERVICE PROVIDERS 5.1.5 END USERS 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 THREAT OF NEW ENTRANTS 5.2.2 BARGAINING POWER OF SUPPLIERS 5.2.3 BARGAINING POWER OF BUYERS 5.2.4 THREAT OF SUBSTITUTES 5.2.5 INTENSITY OF RIVALRY 6 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY COMPONENT 6.1 OVERVIEW 6.1.1 MARKET ESTIMATES & FORECAST, 2019–2027 6.1.2 HARDWARE 6.1.2.1 SENSORS 6.1.2.2 DATA LOGGERS 6.1.2.3 REAL-TIME MONITORING DEVICES 6.1.2.4 RFID DEVICES 6.1.2.5 RESISTANCE TEMPERATURE DETECTORS 6.1.2.6 OTHERS 6.1.3 SOFTWARE 6.1.3.1 CLOUD BASED 6.1.3.2 ON-PREMISES 7 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY TEMPERATURE TYPE 7.1 OVERVIEW 7.1.1 MARKET ESTIMATES & FORECAST, 2019–2027 7.1.2 FROZEN 7.1.3 CHILLED 8 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY PRODUCT 8.1 OVERVIEW 8.1.1 MARKET ESTIMATES & FORECAST, 2019–2027 8.1.2 VACCINES 8.1.3 BIOPHARMACEUTICALS 8.1.4 CLINICAL TRIAL MATERIALS 8.1.5 OTHERS 9 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY END-USER 9.1 OVERVIEW 9.1.1 MARKET ESTIMATES & FORECAST, 2019–2027 9.1.2 BIOPHARMACEUTICAL COMPANIES 9.1.3 HOSPITAL & CLINICS 9.1.4 RESEARCH INSTITUTES 9.1.5 OTHERS 10 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY REGION 10.1 OVERVIEW 10.1.1 MARKET ESTIMATES & FORECAST, 2019–2027 10.2 NORTH AMERICA 10.2.1 US 10.2.2 CANADA 10.2.3 MEXICO 10.3 EUROPE 10.3.1 UK 10.3.2 GERMANY 10.3.3 FRANCE 10.3.4 ITALY 10.3.5 SPAIN 10.3.6 RUSSIA 10.3.7 NETHERLAND 10.3.8 FINLAND 10.3.9 BELGIUM 10.3.10 POLAND 10.3.11 REST OF EUROPE 10.4 ASIA-PACIFIC 10.4.1 CHINA 10.4.2 JAPAN 10.4.3 INDIA 10.4.4 REST OF ASIA-PACIFIC 10.5 REST OF THE WORLD 10.5.1 MIDDLE EAST & AFRICA 10.5.2 CENTRAL & SOUTH AMERICA 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 11.2 MARKET SHARE ANALYSIS 11.3 COMPETITIVE BENCHMARKING 11.4 COMPETITOR DASHBOARD 11.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.5.1 PRODUCT LAUNCHES/PRODUCT DEVELOPMENTS/SERVICE DEPLOYMENTS 11.5.2 MERGERS&ACQUISITIONS/EXPANSIONS/PARTNERSHIPS/JOINT VENTURES 12 COMPANY PROFILE 12.1 CARRIER 12.1.1 COMPANY OVERVIEW 12.1.2 FINANCIAL OVERVIEW 12.1.3 SOLUTIONS OFFERED 12.1.4 KEY DEVELOPMENTS 12.1.5 SWOT ANALYSIS 12.1.6 KEY STRATEGIES 12.2 MONNIT CORPORATION 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 SOLUTIONS OFFERED 12.2.4 PRODUCTS OFFERED 12.2.5 KEY DEVELOPMENTS 12.2.6 SWOT ANALYSIS 12.2.7 KEY STRATEGIES 12.3 BERLINGER & CO. AG 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 SOLUTIONS OFFERED 12.3.4 KEY DEVELOPMENTS 12.3.5 SWOT ANALYSIS 12.3.6 KEY STRATEGIES 12.4 TESTO SE & CO. KGAA 12.4.1 COMPANY OVERVIEW 12.4.2 FINANCIAL OVERVIEW 12.4.3 PRODUCTS OFFERED 12.4.4 KEY DEVELOPMENTS 12.4.5 SWOT ANALYSIS 12.4.6 KEY STRATEGIES 12.5 EMERSON ELECTRIC CO. 12.5.1 COMPANY OVERVIEW 12.5.2 FINANCIAL OVERVIEW 12.5.3 PRODUCTS OFFERED 12.5.4 KEY DEVELOPMENTS 12.5.5 SWOT ANALYSIS 12.5.6 KEY STRATEGIES 12.6 SIGNATROL 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS OFFERED 12.6.4 KEY DEVELOPMENTS 12.6.5 KEY STRATEGIES 12.7 HAIER BIOMEDICAL 12.7.1 COMPANY OVERVIEW 12.7.2 FINANCIAL OVERVIEW 12.7.3 PRODUCTS OFFERED 12.7.4 KEY DEVELOPMENTS 12.7.5 KEY STRATEGIES 12.8 TEMPTIME CORPORATION 12.8.1 COMPANY OVERVIEW 12.8.2 FINANCIAL OVERVIEW 12.8.3 PRODUCTS OFFERED 12.8.4 KEY DEVELOPMENTS 12.8.5 KEY STRATEGIES 12.9 COLD CHAIN TECHNOLOGIES 12.9.1 COMPANY OVERVIEW 12.9.2 FINANCIAL OVERVIEW 12.9.3 PRODUCTS OFFERED 12.9.4 KEY DEVELOPMENTS 12.9.5 KEY STRATEGIES 12.10 DICKSON 12.10.1 COMPANY OVERVIEW 12.10.2 FINANCIAL OVERVIEW 12.10.3 PRODUCTS OFFERED 12.10.4 KEY DEVELOPMENTS 12.11 SPOTSEE 12.11.1 COMPANY OVERVIEW 12.11.2 FINANCIAL OVERVIEW 12.11.3 PRODUCTS OFFERED 12.11.4 KEY DEVELOPMENT 12.11.5 KEY STRATEGIES 12.12 ROTRONIC AG 12.12.1 COMPANY OVERVIEW 12.12.2 FINANCIAL OVERVIEW 12.12.3 PRODUCTS OFFERED 12.12.4 KEY DEVELOPMENTS 12.12.5 KEY STRATEGIES 12.13 ELPRO-BUCHS AG 12.13.1 COMPANY OVERVIEW 12.13.2 FINANCIAL OVERVIEW 12.13.3 SOLUTIONS OFFERED 12.13.4 KEY DEVELOPMENTS 12.13.5 SWOT ANALYSIS 12.13.6 KEY STRATEGIES 12.14 CONTROLANT 12.14.1 COMPANY OVERVIEW 12.14.2 FINANCIAL OVERVIEW 12.14.3 SOLUTIONS OFFERED 12.14.4 KEY DEVELOPMENTS 12.14.5 SWOT ANALYSIS 12.14.6 KEY STRATEGIES 12.15 ROAMBEE CORPORATION 12.15.1 COMPANY OVERVIEW 12.15.2 FINANCIAL OVERVIEW 12.15.3 SERVICES OFFERED 12.15.4 KEY DEVELOPMENTS 12.15.5 SWOT ANALYSIS 12.15.6 KEY STRATEGIES 12.16 ONASSET INTELLIGENCE, INC. 12.16.1 COMPANY OVERVIEW 12.16.2 FINANCIAL OVERVIEW 12.16.3 PRODUCTS OFFERED 12.16.4 KEY DEVELOPMENTS 12.16.5 SWOT ANALYSIS 12.16.6 KEY STRATEGIES 12.17 TIVE 12.17.1 COMPANY OVERVIEW 12.17.2 FINANCIAL OVERVIEW 12.17.3 SOLUTIONS OFFERED 12.17.4 KEY DEVELOPMENTS 12.17.5 SWOT ANALYSIS 12.17.6 KEY STRATEGIES

Companies Mentioned

Carrier (US) Monnit Corporation (US) Temptime Corporation (US) Cold Chain Technologies (US) Dickson (US) Spotsee (US) Berlinger & Co. AG (Switzerland) Testo SE & Co. KGaA (Germany) Emerson (US) Signatrol (UK) Haier Biomedical (Shandong) Rotronic (Switzerland) Elpro (Switzerland) Controlant (Iceland) Roambee Corporation (California) OnAsset Intelligence Inc. (US) Tive (US).

Reviews

There are no reviews yet.

Be the first to review “Healthcare Cold Chain Monitoring Market—Forecast till 2027”

Related products